These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17052808)

  • 21. Effect of peroxisome proliferator-activated receptor-alpha ligands in the interaction between adipocytes and macrophages in obese adipose tissue.
    Toyoda T; Kamei Y; Kato H; Sugita S; Takeya M; Suganami T; Ogawa Y
    Obesity (Silver Spring); 2008 Jun; 16(6):1199-207. PubMed ID: 18356826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of PPAR alpha in obesity.
    Seedorf U; Assmann G
    Nutr Metab Cardiovasc Dis; 2001 Jun; 11(3):189-94. PubMed ID: 11590995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism.
    Giaginis C; Tsantili-Kakoulidou A; Theocharis S
    Fundam Clin Pharmacol; 2007 Jun; 21(3):231-44. PubMed ID: 17521292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Peroxisome proliferator-activated receptors and atherosclerosis].
    Jin N; Wang X
    Sheng Li Ke Xue Jin Zhan; 2004 Jan; 35(1):13-8. PubMed ID: 15127591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The selected pathophysiological aspects of PPARs activation.
    Kieć-Wilk B; Dembińska-Kieć A; Olszanecka A; Bodzioch M; Kawecka-Jaszcz K
    J Physiol Pharmacol; 2005 Jun; 56(2):149-62. PubMed ID: 15985699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adipocyte insensitivity syndromes -- novel approach to nutritional metabolic problems including obesity and obesity related disorders.
    Erol A
    Med Hypotheses; 2005; 64(4):826-32. PubMed ID: 15694704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.
    Bays HE; González-Campoy JM; Bray GA; Kitabchi AE; Bergman DA; Schorr AB; Rodbard HW; Henry RR
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):343-68. PubMed ID: 18327995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
    Michalik L; Auwerx J; Berger JP; Chatterjee VK; Glass CK; Gonzalez FJ; Grimaldi PA; Kadowaki T; Lazar MA; O'Rahilly S; Palmer CN; Plutzky J; Reddy JK; Spiegelman BM; Staels B; Wahli W
    Pharmacol Rev; 2006 Dec; 58(4):726-41. PubMed ID: 17132851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Veterinary aspects and perspectives of nutrigenomics: a critical review.
    Fekete SG; Brown DL
    Acta Vet Hung; 2007 Jun; 55(2):229-39. PubMed ID: 17555288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exercise reduces adipose tissue via cannabinoid receptor type 1 which is regulated by peroxisome proliferator-activated receptor-delta.
    Yan ZC; Liu DY; Zhang LL; Shen CY; Ma QL; Cao TB; Wang LJ; Nie H; Zidek W; Tepel M; Zhu ZM
    Biochem Biophys Res Commun; 2007 Mar; 354(2):427-33. PubMed ID: 17223076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epoxygenases and peroxisome proliferator-activated receptors in mammalian vascular biology.
    Wray J; Bishop-Bailey D
    Exp Physiol; 2008 Jan; 93(1):148-54. PubMed ID: 17872966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adipose tissue: from lipid storage compartment to endocrine organ.
    Scherer PE
    Diabetes; 2006 Jun; 55(6):1537-45. PubMed ID: 16731815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of peroxisome proliferator-activated receptor agonists.
    Chang F; Jaber LA; Berlie HD; O'Connell MB
    Ann Pharmacother; 2007 Jun; 41(6):973-83. PubMed ID: 17519293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PPAR and Pain.
    Maeda T; Kishioka S
    Int Rev Neurobiol; 2009; 85():165-77. PubMed ID: 19607969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PPARs and the orchestration of metabolic fuel selection.
    Sugden MC; Zariwala MG; Holness MJ
    Pharmacol Res; 2009 Sep; 60(3):141-50. PubMed ID: 19646653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex-differential expression of metabolism-related genes in response to a high-fat diet.
    Priego T; Sánchez J; Picó C; Palou A
    Obesity (Silver Spring); 2008 Apr; 16(4):819-26. PubMed ID: 18239587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets.
    Brown JD; Plutzky J
    Circulation; 2007 Jan; 115(4):518-33. PubMed ID: 17261671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RAR/RXR and PPAR/RXR signaling in neurological and psychiatric diseases.
    van Neerven S; Kampmann E; Mey J
    Prog Neurobiol; 2008 Aug; 85(4):433-51. PubMed ID: 18554773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of medium- and long-chain fatty acid diets on PPAR and SREBP-1 expression and glucose homeostasis in ACBP-overexpressing transgenic rats.
    Oikari S; Ahtialansaari T; Huotari A; Kiehne K; Fölsch UR; Wolffram S; Jänne J; Alhonen L; Herzig KH
    Acta Physiol (Oxf); 2008 Sep; 194(1):57-65. PubMed ID: 18394026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cloning, expression and investigation for polymorphisms of canine peroxisome proliferator-activated receptors.
    Nishii N; Takasu M; Soe OK; Maeda S; Ohba Y; Inoue-Murayama M; Kitagawa H
    Comp Biochem Physiol B Biochem Mol Biol; 2007 Aug; 147(4):690-7. PubMed ID: 17512769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.